APA (7th ed.) Citation

A, M., B, H., A, A., MKB, B., D, I., R, U., . . . SMD, R. (2022). Dithymoquinone Analogues as Potential Candidate(s) for Neurological Manifestation Associated with COVID-19: A Therapeutic Strategy for Neuro-COVID. Life (Basel, Switzerland), 12(7), . https://doi.org/10.3390/life12071076

Chicago Style (17th ed.) Citation

A, Moin, et al. "Dithymoquinone Analogues as Potential Candidate(s) for Neurological Manifestation Associated with COVID-19: A Therapeutic Strategy for Neuro-COVID." Life (Basel, Switzerland) 12, no. 7 (2022). https://doi.org/10.3390/life12071076.

MLA (9th ed.) Citation

A, Moin, et al. "Dithymoquinone Analogues as Potential Candidate(s) for Neurological Manifestation Associated with COVID-19: A Therapeutic Strategy for Neuro-COVID." Life (Basel, Switzerland), vol. 12, no. 7, 2022, https://doi.org/10.3390/life12071076.